Q1 2011

Source filing unavailable

Q1 2011 · —

Revenue

$824.63K

no prior Q1 2010 on file

Net Income

-$3.36M

no prior Q1 2010 on file

EPS Diluted

-$0.07

no prior Q1 2010 on file

Operating Income-$4,027,887—

Operating Cash Flow-$3,357,439—

Free Cash Flowderived

Same quarter

no prior Q1 2010 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Lineage Cell Therapeutics, Inc. · CIK 876343 · Engraved from SEC EDGAR